Mucopolysaccharidosis type IX (MPS IX, hyaluronidase deficiency, Natowicz syndrome) is an extremely rare autosomal recessive lysosomal storage disorder caused by deficiency of lysosomal hyaluronidase 1 (HYAL1). Unlike the other mucopolysaccharidoses, the stored glycosaminoglycan is hyaluronan (hyaluronic acid) rather than a sulfated GAG (dermatan, heparan, or keratan sulfate). Because hyaluronan is concentrated in synovial fluid, cartilage, and skin rather than in the tissues affected by the sulfated GAGs, MPS IX has a surprisingly mild phenotype dominated by periarticular soft-tissue masses, episodic painful joint swelling, mild short stature, and acetabular erosions, with a notable absence of the neurological, visceral, corneal, and severe skeletal involvement seen in the sulfated-GAG mucopolysaccharidoses. Only a handful of patients have ever been reported, the first by Natowicz and colleagues in 1996. Management is supportive and symptomatic; no enzyme replacement therapy is approved.
Ask a research question about Mucopolysaccharidosis type IX. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Mucopolysaccharidosis type IX
creation_date: "2026-06-12T00:00:00Z"
category: Mendelian
description: >-
Mucopolysaccharidosis type IX (MPS IX, hyaluronidase deficiency, Natowicz
syndrome) is an extremely rare autosomal recessive lysosomal storage disorder
caused by deficiency of lysosomal hyaluronidase 1 (HYAL1). Unlike the other
mucopolysaccharidoses, the stored glycosaminoglycan is hyaluronan (hyaluronic
acid) rather than a sulfated GAG (dermatan, heparan, or keratan sulfate).
Because hyaluronan is concentrated in synovial fluid, cartilage, and skin
rather than in the tissues affected by the sulfated GAGs, MPS IX has a
surprisingly mild phenotype dominated by periarticular soft-tissue masses,
episodic painful joint swelling, mild short stature, and acetabular erosions,
with a notable absence of the neurological, visceral, corneal, and severe
skeletal involvement seen in the sulfated-GAG mucopolysaccharidoses. Only a
handful of patients have ever been reported, the first by Natowicz and
colleagues in 1996. Management is supportive and symptomatic; no enzyme
replacement therapy is approved.
disease_term:
preferred_term: Mucopolysaccharidosis type IX
term:
id: MONDO:0011093
label: mucopolysaccharidosis type 9
mappings:
mondo_mappings:
- term:
id: MONDO:0011093
label: mucopolysaccharidosis type 9
mapping_predicate: skos:exactMatch
mapping_source: MONDO
parents:
- Mucopolysaccharidosis
- Lysosomal Storage Disorder
synonyms:
- hyaluronidase deficiency
- Natowicz syndrome
- MPS IX
- MPS9
notes: >-
MPS IX is biochemically distinct from the other mucopolysaccharidoses because
the undegraded substrate is the non-sulfated glycosaminoglycan hyaluronan,
not dermatan, heparan, or keratan sulfate. Consequently, the canonical
sulfated-GAG tissue arms of the mps_gag_storage module (heparan-sulfate
neuronopathic, dermatan-sulfate somatic/connective-tissue, keratan-sulfate
skeletal-dysplasia) are not engaged; the periarticular/synovial phenotype of
MPS IX is an orphan case relative to those arms. Only the GAG-accumulation hub
of the module is wired here. Hyaluronan is enriched in synovial fluid,
cartilage, and skin, which is consistent with the joint-centred clinical
picture. The evidence base is sparse: only a few patients have ever been
reported, so well-established but minimally documented features (e.g.
acetabular erosions, autosomal recessive segregation in the index family,
high serum hyaluronan) are described in prose rather than over-annotated with
evidence beyond the primary reports.
inheritance:
- name: Autosomal recessive inheritance
inheritance_term:
preferred_term: Autosomal recessive inheritance
term:
id: HP:0000007
label: Autosomal recessive inheritance
description: >-
MPS IX is inherited in an autosomal recessive manner. The index patient was
a compound heterozygote for two HYAL1 mutations, consistent with autosomal
recessive segregation reported in the family.
evidence:
- reference: PMID:10339581
reference_title: "Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We identified two mutations in the HYAL1 alleles of the patient, a 1412G --> A mutation that introduces a nonconservative amino acid substitution (Glu268Lys) in a putative active site residue and a complex intragenic rearrangement, 1361del37ins14, that results in a premature termination codon."
explanation: >-
The index patient carried two distinct HYAL1 mutations (compound
heterozygosity), consistent with autosomal recessive inheritance of MPS IX.
pathophysiology:
- name: HYAL1 hyaluronidase deficiency
description: >-
Biallelic loss-of-function variants in HYAL1 cause deficiency of lysosomal
hyaluronidase 1, the endoglycosidase that degrades hyaluronan. Loss of this
activity blocks the endoglycosidic breakdown of hyaluronan that is required
for its lysosomal turnover.
genes:
- preferred_term: HYAL1
term:
id: hgnc:5320
label: HYAL1
molecular_functions:
- preferred_term: hyalurononglucosaminidase activity
modifier: DECREASED
term:
id: GO:0004415
label: hyalurononglucosaminidase activity
biological_processes:
- preferred_term: hyaluronan catabolic process
modifier: DECREASED
term:
id: GO:0030214
label: hyaluronan catabolic process
evidence:
- reference: PMID:10339581
reference_title: "Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The turnover of HA requires endoglycosidic breakdown by lysosomal hyaluronidase, and a congenital deficiency of hyaluronidase has been thought to be incompatible with life."
explanation: >-
Establishes that lysosomal hyaluronidase is required for hyaluronan
turnover; its congenital deficiency is the proximal defect in MPS IX.
- reference: PMID:10339581
reference_title: "Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "These genes, HYAL1 and HYAL2, encode two distinct lysosomal hyaluronidases with different substrate specificities."
explanation: >-
Identifies HYAL1 as encoding a lysosomal hyaluronidase, the enzyme
deficient in MPS IX.
downstream:
- target: Lysosomal hyaluronan accumulation
causal_link_type: DIRECT
description: >-
Loss of hyaluronidase 1 activity leaves hyaluronan undegraded, so it
accumulates within lysosomes.
evidence:
- reference: PMID:10339581
reference_title: "Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "This patient had a surprisingly mild clinical phenotype, including notable periarticular soft tissue masses, mild short stature, an absence of neurological or visceral involvement, and histological and ultrastructural evidence of a lysosomal storage disease."
explanation: >-
Histological and ultrastructural evidence of lysosomal storage in the
hyaluronidase-deficient patient supports lysosomal accumulation of the
undegraded substrate.
- name: Lysosomal hyaluronan accumulation
conforms_to: "mps_gag_storage#Lysosomal GAG Accumulation"
description: >-
Undegraded hyaluronan accumulates within lysosomes. This is the
GAG-accumulation hub of the mps_gag_storage module, but unlike the sulfated
GAGs, hyaluronan does not engage the heparan-sulfate neuronopathic,
dermatan-sulfate somatic, or keratan-sulfate skeletal arms. Hyaluronan is
instead enriched in synovial fluid, cartilage, and skin, directing the
downstream pathology toward the joints rather than toward the
central nervous system, viscera, cornea, or generalized skeleton. This
tissue distribution underlies the unexpectedly mild, joint-centred phenotype
of MPS IX.
chemical_entities:
- preferred_term: hyaluronan
term:
id: CHEBI:16336
label: hyaluronic acid
modifier: INCREASED
cellular_components:
- preferred_term: lysosome
term:
id: GO:0005764
label: lysosome
cell_types:
- preferred_term: fibroblast
term:
id: CL:0000057
label: fibroblast
- preferred_term: synovial cell
term:
id: CL:0000214
label: synovial cell
- preferred_term: tissue histiocyte (macrophage)
term:
id: CL:0000235
label: macrophage
locations:
- preferred_term: synovial joint
term:
id: UBERON:0002217
label: synovial joint
- preferred_term: synovial fluid
term:
id: UBERON:0001090
label: synovial fluid
biological_processes:
- preferred_term: hyaluronan catabolic process
modifier: DECREASED
term:
id: GO:0030214
label: hyaluronan catabolic process
evidence:
- reference: PMID:10339581
reference_title: "Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Hyaluronan (HA), a large glycosaminoglycan abundant in the extracellular matrix, is important in cell migration during embryonic development, cellular proliferation, and differentiation and has a structural role in connective tissues."
explanation: >-
Identifies the stored substrate as hyaluronan, a glycosaminoglycan of the
extracellular matrix and connective tissue, distinguishing MPS IX from the
sulfated-GAG mucopolysaccharidoses.
- reference: PMID:10339581
reference_title: "Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "These data provide an explanation for the unexpectedly mild phenotype in mucopolysaccharidosis IX and predict the existence of other hyaluronidase deficiency disorders."
explanation: >-
The restricted tissue impact of hyaluronan storage accounts for the
unexpectedly mild MPS IX phenotype, consistent with the hub not engaging
the sulfated-GAG tissue arms of the module.
downstream:
- target: Periarticular soft-tissue masses and joint disease
causal_link_type: DIRECT
description: >-
Hyaluronan storage in and around joints produces periarticular
soft-tissue masses and joint disease.
evidence:
- reference: PMID:10339581
reference_title: "Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "This patient had a surprisingly mild clinical phenotype, including notable periarticular soft tissue masses, mild short stature, an absence of neurological or visceral involvement, and histological and ultrastructural evidence of a lysosomal storage disease."
explanation: >-
Directly links the hyaluronidase-deficiency storage state to
periarticular soft-tissue masses and the broader mild joint-centred
phenotype.
- name: Periarticular soft-tissue masses and joint disease
description: >-
The characteristic clinical expression of MPS IX is periarticular
soft-tissue masses with episodic painful joint swelling, together with mild
short stature and acetabular erosions. Neurological and visceral involvement
are absent. Some later-reported patients are clinically indistinguishable
from juvenile idiopathic arthritis, with proliferative synovitis.
locations:
- preferred_term: synovial joint
term:
id: UBERON:0002217
label: synovial joint
evidence:
- reference: PMID:10339581
reference_title: "Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "This patient had a surprisingly mild clinical phenotype, including notable periarticular soft tissue masses, mild short stature, an absence of neurological or visceral involvement, and histological and ultrastructural evidence of a lysosomal storage disease."
explanation: >-
Defines the core MPS IX phenotype cluster: periarticular soft-tissue
masses and mild short stature, with absent neurological/visceral disease.
- reference: PMID:26122630
reference_title: "Screening Mucopolysaccharidosis Type IX in Patients with Juvenile Idiopathic Arthritis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The first reported patient had mild short stature and periarticular soft tissue masses; the other reported patients are clinically indistinguishable from juvenile idiopathic arthritis."
explanation: >-
Confirms the joint-centred phenotype across the few reported patients,
including a JIA-like presentation in later cases.
downstream:
- target: Periarticular soft-tissue masses
causal_link_type: DIRECT
description: Hyaluronan storage produces periarticular soft-tissue masses.
- target: Joint swelling
causal_link_type: DIRECT
description: Joint-centered hyaluronan storage manifests as episodic painful joint swelling.
- target: Short stature
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
description: The joint-centered lysosomal storage phenotype includes mild short stature.
phenotypes:
- name: Periarticular soft-tissue masses
category: Musculoskeletal
description: >-
Notable periarticular soft-tissue masses, accompanied by episodes of painful
joint swelling, are the hallmark feature of MPS IX. No precise HPO term
exists for periarticular soft-tissue masses, so this is annotated to the
closest available term, Joint swelling.
phenotype_term:
preferred_term: Periarticular soft-tissue masses with joint swelling
term:
id: HP:0001386
label: Joint swelling
evidence:
- reference: PMID:10339581
reference_title: "Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "This patient had a surprisingly mild clinical phenotype, including notable periarticular soft tissue masses, mild short stature, an absence of neurological or visceral involvement, and histological and ultrastructural evidence of a lysosomal storage disease."
explanation: >-
Directly documents periarticular soft-tissue masses as a defining MPS IX
feature.
- reference: PMID:26122630
reference_title: "Screening Mucopolysaccharidosis Type IX in Patients with Juvenile Idiopathic Arthritis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The first reported patient had mild short stature and periarticular soft tissue masses; the other reported patients are clinically indistinguishable from juvenile idiopathic arthritis."
explanation: >-
Independently confirms periarticular soft-tissue masses in the index MPS IX
patient.
- name: Short stature
category: Growth
description: >-
Mild short stature is part of the MPS IX phenotype and is notably milder than
the disproportionate short stature of the sulfated-GAG mucopolysaccharidoses.
phenotype_term:
preferred_term: Mild short stature
term:
id: HP:0004322
label: Short stature
severity: MILD
evidence:
- reference: PMID:10339581
reference_title: "Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "This patient had a surprisingly mild clinical phenotype, including notable periarticular soft tissue masses, mild short stature, an absence of neurological or visceral involvement, and histological and ultrastructural evidence of a lysosomal storage disease."
explanation: >-
Directly documents mild short stature as a core MPS IX feature.
- reference: PMID:26122630
reference_title: "Screening Mucopolysaccharidosis Type IX in Patients with Juvenile Idiopathic Arthritis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The first reported patient had mild short stature and periarticular soft tissue masses; the other reported patients are clinically indistinguishable from juvenile idiopathic arthritis."
explanation: >-
Independently confirms mild short stature in the first reported MPS IX
patient.
- name: Joint swelling
category: Musculoskeletal
description: >-
Episodic painful joint swelling occurs in MPS IX, sometimes mimicking
juvenile idiopathic arthritis with proliferative synovitis.
phenotype_term:
preferred_term: Episodic painful joint swelling
term:
id: HP:0001386
label: Joint swelling
temporality: RECURRENT
evidence:
- reference: PMID:26122630
reference_title: "Screening Mucopolysaccharidosis Type IX in Patients with Juvenile Idiopathic Arthritis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The first reported patient had mild short stature and periarticular soft tissue masses; the other reported patients are clinically indistinguishable from juvenile idiopathic arthritis."
explanation: >-
The JIA-indistinguishable presentation of later patients supports
inflammatory joint swelling as part of the MPS IX phenotype.
genetic:
- name: HYAL1 pathogenic variants
gene_term:
preferred_term: HYAL1
term:
id: hgnc:5320
label: HYAL1
association: Causative
inheritance:
- name: Autosomal recessive
description: >-
MPS IX results from biallelic HYAL1 variants; the index patient was a
compound heterozygote.
evidence:
- reference: PMID:10339581
reference_title: "Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We identified two mutations in the HYAL1 alleles of the patient, a 1412G --> A mutation that introduces a nonconservative amino acid substitution (Glu268Lys) in a putative active site residue and a complex intragenic rearrangement, 1361del37ins14, that results in a premature termination codon."
explanation: >-
Two distinct HYAL1 alleles in the patient support biallelic (compound
heterozygous) autosomal recessive disease.
features: >-
MPS IX is caused by biallelic loss-of-function variants in HYAL1, which
encodes lysosomal hyaluronidase 1. The originally described patient was a
compound heterozygote for a missense variant affecting a putative active-site
residue (Glu268Lys) and a complex intragenic rearrangement producing a
premature termination codon. HYAL1 and the adjacent HYAL2/HYAL3 genes have
distinct tissue expression patterns, which helps explain why HYAL1 deficiency
produces such a restricted, mild phenotype.
evidence:
- reference: PMID:10339581
reference_title: "Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We further show that these two hyaluronidase genes, as well as a third recently discovered adjacent hyaluronidase gene, HYAL3, have markedly different tissue expression patterns, consistent with differing roles in HA metabolism."
explanation: >-
Documents HYAL1 within the tandem HYAL1/HYAL2/HYAL3 cluster and the
distinct tissue expression that underlies the restricted MPS IX phenotype.
treatments:
- name: Supportive and symptomatic care
description: >-
There is no approved enzyme replacement therapy or other disease-modifying
treatment for MPS IX. Management is supportive and symptomatic, directed at
joint pain, swelling, and the periarticular soft-tissue masses (e.g.
analgesia/anti-inflammatory measures and orthopaedic/symptomatic care).
therapeutic_modality: OTHER
treatment_term:
preferred_term: supportive care
term:
id: MAXO:0000950
label: supportive care
prevalence:
- population: Worldwide
notes: >-
MPS IX is the rarest mucopolysaccharidosis; only a handful of patients have
ever been reported in the literature.
evidence:
- reference: PMID:26122630
reference_title: "Screening Mucopolysaccharidosis Type IX in Patients with Juvenile Idiopathic Arthritis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Mucopolysaccharidosis type IX is the rarest form of mucopolysaccharidosis. To date, only four patients have been reported."
explanation: >-
Directly supports the extreme rarity of MPS IX.